NCT03477474View on ClinicalTrials.gov

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

TerminatedOBSERVATIONAL
Enrollment

311

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Non-small Cell Lung Cancer Metastatic
Trial Locations (1)

33308

Holy Cross, Fort Lauderdale

Sponsors
All Listed Sponsors
lead

Guardant Health, Inc.

INDUSTRY